Search

Author/Creator Xu, R

1. Measuring human capital: a systematic analysis of 195 countries and territories, 1990–2016. Issue 10154 (6th October 2018)

Authors:
Lim, Stephen S; Updike, Rachel L; Kaldjian, Alexander S; Barber, Ryan M; Cowling, Krycia; York, Hunter; Friedman, Joseph; Xu, R; Whisnant, Joanna L; Taylor, Heather J; Leever, Andrew T; Roman, Yesenia; Bryant, Miranda F; Dieleman, Joseph; Gakidou, Emmanuela; Murray, Christopher J L
Journal:
Lancet
Issue:
Volume 392:Issue 10154(2018)
Page Start:
1217
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P-297CanStem303C trial: A Phase 3 Study of napabucasin (NAPA) in combination with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in adult patients (pts) with previously treated metastatic colorectal cancer (mCRC) - Trial in progress. (20th June 2018)

Authors:
Shah, M; Grothey, A; Tebbutt, N; Xu, R; Yoshino, T; Cervantes, A; Tabernero, J; Taieb, J; Falcone, A; Xu, B; Fontaine, M; Borodyansky, L; Van Cutsem, E
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P-297CanStem303C trial: A Phase 3 Study of napabucasin (NAPA) in combination with 5-fluorouracil (5-FU), leucovorin, and irinotecan (FOLFIRI) in adult patients (pts) with previously treated metastatic colorectal cancer (mCRC) - Trial in progress. (20th June 2018)

Authors:
Shah, M; Grothey, A; Tebbutt, N; Xu, R; Yoshino, T; Cervantes, A; Tabernero, J; Taieb, J; Falcone, A; Xu, B; Fontaine, M; Borodyansky, L; Van Cutsem, E
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 1150PRecombinant humanized anti-PD-1 monoclonal antibody (JS001) in patients with refractory/metastatic nasopharyngeal carcinoma: Preliminary results of an open-label phase II clinical study. (23rd October 2018)

Authors:
Xu, R; Wang, F H; Feng, F J; Li, Q; Xu, N; Hu, X C; Liao, W J; Jiang, Y; Lin, X; Zhang, Q Y; Yuan, X L; Huang, H X; Chen, Y; Dai, G H; Shi, J H; Shen, L; Ren, C; Wu, H; Feng, H; Yao, S
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗